129 related articles for article (PubMed ID: 36556165)
1. Risk Factors Associated with CIN2+ in Spanish Patients with L-SIL/ASCUS Cytology Collected from a Madrid Hospital.
González González V; Ramírez Mena M; Herráiz Martínez MÁ; Serrano García I; Coronado Martín PJ
J Pers Med; 2022 Nov; 12(12):. PubMed ID: 36556165
[TBL] [Abstract][Full Text] [Related]
2. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
Ferris DG; Wright TC; Litaker MS; Richart RM; Lorincz AT; Sun XW; Borgatta L; Buck H; Kramer L; Rubin R
J Fam Pract; 1998 Feb; 46(2):125-34. PubMed ID: 9487318
[TBL] [Abstract][Full Text] [Related]
3. Analysis of New Colposcopy Techniques in the Diagnosis and Evolution of SIL/CIN: Comparison of Colposcopy with the DSI System (COLPO-DSI Study).
González González V; Ramírez Mena MDM; Calvo Torres J; Herráiz Martínez MÁ; Serrano García I; Coronado P
J Pers Med; 2023 Nov; 13(11):. PubMed ID: 38003920
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
[TBL] [Abstract][Full Text] [Related]
5. Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia.
Almog B; Gamzu R; Kuperminc MJ; Levin I; Fainaru O; Niv J; Bar-Am A
Gynecol Oncol; 2003 Mar; 88(3):345-50. PubMed ID: 12648585
[TBL] [Abstract][Full Text] [Related]
6. HPV DNA testing improves CIN2+ risk stratification and detection of CIN2+ in delayed triage of ASCUS and LSIL. A population-based follow-up study from Western Norway.
Budal EB; Haugland HK; Skar R; Maehle BO; Bjørge T; Vintermyr OK
Cancer Med; 2014 Feb; 3(1):182-9. PubMed ID: 24403090
[TBL] [Abstract][Full Text] [Related]
7. Can biopsies be omitted after normal colposcopy in women referred with low-grade cervical cytology? A prospective cohort study.
Jespersen MM; Booth BB; Petersen LK
BMC Womens Health; 2021 Nov; 21(1):394. PubMed ID: 34798899
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of atypical and low-grade cervical cytology in private practice.
Nyirjesy I; Billingsley FS; Forman MR
Obstet Gynecol; 1998 Oct; 92(4 Pt 1):601-7. PubMed ID: 9764636
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease.
Kreimer AR; Guido RS; Solomon D; Schiffman M; Wacholder S; Jeronimo J; Wheeler CM; Castle PE
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):908-14. PubMed ID: 16702369
[TBL] [Abstract][Full Text] [Related]
10. Over Expressed TKTL1, CIP-2A, and B-MYB Proteins in Uterine Cervix Epithelium Scrapings as Potential Risk Predictive Biomarkers in HR-HPV-Infected LSIL/ASCUS Patients.
Chiarini A; Liu D; Rassu M; Armato U; Eccher C; Dal Prà I
Front Oncol; 2019; 9():213. PubMed ID: 31001477
[TBL] [Abstract][Full Text] [Related]
11. The utility of high-risk HPV testing in the management of women 30 to 64 years of age with low-grade squamous intraepithelial lesions on cervical cytology.
Selvaggi SM
J Am Soc Cytopathol; 2015; 4(5):290-293. PubMed ID: 31051767
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity and specificity values of high-risk HPV DNA, p16/ki-67 and HPV mRNA in young women with atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesion (LSIL).
Frega A; Pavone M; Sesti F; Leone C; Bianchi P; Cozza G; Colombrino C; Lukic A; Marziani R; De Sanctis L; Delli Carpini G; Caserta D; Ciavattini A
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10672-10677. PubMed ID: 31858534
[TBL] [Abstract][Full Text] [Related]
13. Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology.
Ki EY; Park JS; Lee A; Kim TJ; Jin HT; Seo YB; Gen Y; Park MY; Lee SJ
Int J Med Sci; 2019; 16(8):1096-1101. PubMed ID: 31523171
[No Abstract] [Full Text] [Related]
14. Value of colposcopy with dynamic spectral imaging in the detection and evolution of high-grade cervical lesions.
Coronado Martín PJ; González González V; Fasero Láiz M
Expert Rev Med Devices; 2022 Jun; 19(6):525-532. PubMed ID: 35858486
[TBL] [Abstract][Full Text] [Related]
15. Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS).
Walker JL; Wang SS; Schiffman M; Solomon D;
Am J Obstet Gynecol; 2006 Aug; 195(2):341-8. PubMed ID: 16890545
[TBL] [Abstract][Full Text] [Related]
16. Management of low-grade cervical cytology in young women. Cohort study from Denmark.
St-Martin G; Thamsborg LH; Andersen B; Christensen J; Ejersbo D; Jochumsen K; Johansen T; Larsen LG; Waldstrøm M; Lynge E
Acta Oncol; 2021 Apr; 60(4):444-451. PubMed ID: 33030976
[TBL] [Abstract][Full Text] [Related]
17. Abnormal Pap smear frequency and comparison of repeat cytological follow-up with colposcopy during patient management: the importance of pathologist's guidance in the management.
Arslan E; Gokdagli F; Bozdag H; Vatansever D; Karsy M
North Clin Istanb; 2019; 6(1):69-74. PubMed ID: 31180371
[TBL] [Abstract][Full Text] [Related]
18. Management of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesions of the uterine cervix with human papilloma virus infection among young women aged less than 25 years.
Ryu KJ; Lee S; Min KJ; Hong JH; Song JY; Lee JK; Lee NW
Diagn Cytopathol; 2016 Dec; 44(12):959-963. PubMed ID: 27714942
[TBL] [Abstract][Full Text] [Related]
19. Cytology and human papillomavirus testing 6 to 12 months after ASCUS or LSIL cytology in organized screening to predict high-grade cervical neoplasia between screening rounds.
Tropé A; Sjøborg KD; Nygård M; Røysland K; Campbell S; Alfsen GC; Jonassen CM
J Clin Microbiol; 2012 Jun; 50(6):1927-35. PubMed ID: 22518869
[TBL] [Abstract][Full Text] [Related]
20. Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL Pap smear.
Molden T; Nygård JF; Kraus I; Karlsen F; Nygård M; Skare GB; Skomedal H; Thoresen SO; Hagmar B
Int J Cancer; 2005 May; 114(6):973-6. PubMed ID: 15645423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
